Astral Codex Ten - Link: Troof On Nootropics
Should have signal-boosted this earlier, forgot, sorry. The author of the blog Troof sort of replicated my 2020 nootropics survey. But instead of another survey, they made a recommendation engine. You rated all the nootropics you’d taken, and it compared you to other people and predicted what else you would like. The end result was the same: lots of people providing data on which nootropics they liked. Troof got 1981 subjects - more than twice as many as I did - and here were their results: This is hard to compare to my survey - it has some different chemicals, and includes a few things that aren’t chemicals at all like meditation and exercise. But the things that both surveys share are in a pretty similar order. I think we have mostly gotten what we can get out of this methodology, without many big surprises. Why do I say this in such a resigned-sounding tone, as opposed to a more triumphant “the results have replicated, so we’re now sure they’re true”? The surveys show that:
We should sort of expect all of these things to be true. People wouldn’t keep doing difficult lifestyle interventions unless they worked; the truly useless ones have probably fallen into obscurity. People wouldn’t risk addictive or illegal things unless they had impressive effects. But it also seems kind of suspicious for placebo effects. People go through a lot of trouble to do something and then figure it must work. If something’s too cheap or easy or boring, they forget about it. I’m especially concerned by psilocybin microdosing, which ranked 8th of almost 150 interventions. Several double-blind studies have now shown this doesn’t work (eg). Worse, in unblinded studies, it seems to “work” best for the people who most strongly believe it will work, and seems to have whatever effect these people believe it will have. This is most likely a very exciting-sounding intervention that doesn’t work at all, and it was one of the very highest-rated on this survey. Meanwhile, SAMe, which has been shown to work well in RCT after RCT, is one of the lowest-rated. To put this another way: if you made a model combining some measure of “how hard is this chemical to obtain / how hard is this lifestyle intervention to practice?” and “how novel and high-tech does it feel?”, plus one or two other things like “is this a stimulant?”, it feels like this would predic the results almost perfectly. Does anything stand out as doing substantially worse than the simple model would predict? It really doesn’t. Maybe theanine, a little? I’m grasping at straws. Finally, in my survey, I got impressive results for Zembrin, a certain extract of the kanna plant. This survey fails to replicate that - Zembrin lands exactly where the “how hard is it to get? how fancy is it?” model would predict, which is not very high. I’m not sure why my survey got such strong results. I know I was personally excited about Zembrin, so there’s room for experimenter bias, but I can’t think of how I would have added in the experimenter bias when I was just collecting your ratings. Maybe I bungled the statistics somehow? In any case, it’s a completely average anxiolytic in every way. Thanks to Troof for doing this! They draw some different conclusions from me, which you can read at the end of his post. You’re a free subscriber to Astral Codex Ten. For the full experience, become a paid subscriber. |
Older messages
Contra Dynomight On Sexy In-Laws
Monday, May 16, 2022
...
Open Thread 224
Saturday, May 14, 2022
...
Your Book Review: Consciousness And The Brain
Friday, May 13, 2022
Finalist #1 of the Book Review Contest
Book Review: The Gervais Principle
Tuesday, May 10, 2022
...
Mantic Monday 5/9/22
Tuesday, May 10, 2022
The future of abortion, plus a valiant attempt at market manipulation
You Might Also Like
Cops finally unmask 'LockBit kingpin' after two-month tease [Wed May 8 2024]
Wednesday, May 8, 2024
Hi The Register Subscriber | Log in The Register {* Daily Headlines *} 8 May 2024 Handout of Dmitry Yuryevich Khoroshev from NCA Cops finally unmask 'LockBit kingpin' after two-month tease
A Little Black Dress That’s Just the Right Amount of Little
Wednesday, May 8, 2024
Here's What You Missed on the Strategist The Strategist Every product is independently selected by editors. If you buy something through our links, New York may earn an affiliate commission. A
Daniels, straight up
Tuesday, May 7, 2024
Stormy Daniels offered up the most salacious testimony yet in Trump's criminal trial. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
How a Miami Student’s Package Scam Came Crashing Down
Tuesday, May 7, 2024
Columns and commentary on news, politics, business, and technology from the Intelligencer team. Intelligencer crime The Package King of Miami Matthew Bergwall was a gifted coder who could have gotten a
Those viral veggie choppers?
Tuesday, May 7, 2024
You can do better ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Wednesday Briefing: Israel in Rafah; negotiators in Cairo
Tuesday, May 7, 2024
Also, Stormy Daniels testified in Donald Trump's trial. View in browser|nytimes.com Ad Morning Briefing: Asia Pacific Edition May 8, 2024 Author Headshot By Amelia Nierenberg Good morning. We'
Get Your Mind Into the Sewer
Tuesday, May 7, 2024
"If you live in London, Dr Leon Barron knows what you're up to. He knows what prescribed drugs you're on – painkillers, antidepressants, antipsychotics or beta blockers – and what illicit
How can Washington state create a skilled and adaptable workforce?
Tuesday, May 7, 2024
Lexion acquisition to Docusign latest success story from AI2 | NVIDIA invests in Carbon Robotics ADVERTISEMENT GeekWire SPONSOR MESSAGE: Join the Nordic Innovation Summit, May 13-14: Topics include AI,
☕ Scrub hub
Tuesday, May 7, 2024
Figs's new premium scrubs. May 07, 2024 Retail Brew It's Tuesday, and it looks like the labor market may slow down in the second half of the year after a period of encouraging growth. With
☕ Unfiltered
Tuesday, May 7, 2024
Inside Jolie Skin Co.'s product-seeding strategy. May 07, 2024 Marketing Brew It's Tuesday. To promote its Skittles Littles candy, Skittles is giving one lucky person a rent-free year in a very